<i>CYP2D6</i> genotype can help to predict effectiveness and safety during opioid treatment for chronic low back pain: results from a retrospective study in an Italian cohort.

Dagostino, Concetta; Allegri, Massimo; Napolioni, Valerio; D'Agnelli, Simona; Bignami, Elena; Mutti, Antonio; van Schaik, Ron Hn

CYP2D6 genotype can help to predict effectiveness and safety during opioid treatment for chronic low back pain: results from a retrospective study in an Italian cohort.

Dagostino, Concetta; Allegri, Massimo; Napolioni, Valerio; D'Agnelli, Simona; Bignami, Elena; Mutti, Antonio; van Schaik, Ron Hn.

Afiliação

Dagostino C; Department of Medicine and Surgery, University of Parma, Parma 43126, Italy, concetta.dagostino@unipr.it.
Allegri M; Study In Multidisciplinary Pain Research (SIMPAR), Milan 20100, Italy, concetta.dagostino@unipr.it.
Napolioni V; Study In Multidisciplinary Pain Research (SIMPAR), Milan 20100, Italy, concetta.dagostino@unipr.it.
D'Agnelli S; Anesthesia and Intensive Care Department, IRCCS Multi Medica Hospital, Milan 20099, Italy.
Bignami E; Italian Pain Institute, Milan 20100, Italy.
Mutti A; Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA 94305, USA.
van Schaik RH; Department of Medicine and Surgery, University of Parma, Parma 43126, Italy, concetta.dagostino@unipr.it.

Pharmgenomics Pers Med ; 11: 179-191, 2018.

Article em En | MEDLINE | ID: mdl-30425549